Tudor Investment Corp
CPRX

Tudor Investment Corp’s Catalyst Pharmaceutical CPRX Stock Holding History

Tudor Investment Corp’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$505K Buy
+20,395
New +$486K ﹤0.01% 2812
2025
Q3 		– Sell
-76,088
Closed -$1.65M – 3434
2025
Q2 		$1.65M Buy
76,088
+14,502
+24% +$342K ﹤0.01% 1800
2025
Q1 		$1.49M Buy
61,586
+2,034
+3% +$45.8K 0.01% 1547
2024
Q4 		$1.24M Buy
+59,552
New +$1.28M ﹤0.01% 1574
2022
Q4 		– Sell
-73,965
Closed -$949K – 2461
2022
Q3 		$949K Buy
+73,965
New +$877K 0.02% 946

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Tudor Investment Corp's CPRX Position: Q1 2026 in Review

Tudor Investment Corp opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 20,395 shares worth $505K. The stake represents ﹤0.01% of the portfolio and ranks #2812 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in CPRX as recently as Q2 2025.

Tudor Investment Corp first reported a position in CPRX in Q3 2022 and has held it in 5 quarters since. The position peaked at $1.65M in Q2 2025. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Tudor Investment Corp held 20,395 shares of Catalyst Pharmaceutical worth $505K as of Q1 2026.
  • Catalyst Pharmaceutical was a new Tudor Investment Corp position in Q1 2026.
  • Catalyst Pharmaceutical made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2812 holding.
  • Tudor Investment Corp first reported a position in Catalyst Pharmaceutical in Q3 2022 and has held it in 5 quarters since.
  • Tudor Investment Corp's Catalyst Pharmaceutical position peaked at $1.65M in Q2 2025.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.